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Abstract
Background: The effectiveness of bracing patients with IS has not yet been convincingly
established due to a lack of RCTs. Some authors suggest that their results confirm that bracing is
effective; others conclude that the effectiveness of bracing is doubtful or recommend a RCT. The
aim of this study was to establish whether bracing patients with idiopathic scoliosis (IS) in an early
stage will result in at least 5 degrees less mean progression of the curvature compared to the
control group after two years of follow-up.
Methods: A randomized controlled trial was designed. Eligible patients are girls and boys in the
age group 8–15 years whose diagnosis of IS has been established by an orthopedic surgeon, who
have not yet been treated by bracing or surgery, and for whom further growth of physical height
is still expected based on medical examination and maturation characteristics (Risser ? 2). The
Cobb angle of the eligible patient should either be minimally 22 and maximally 29 degrees with
established progression of more than 5 degrees, or should be minimally 30 and maximally 35
degrees; established progression for the latter is not necessary. A total of 100 patients will be
included in this trial. The intervention group will be treated with full-time Boston brace wear; the
control group will not be braced. Every four months, each patient will have a physical and an X-ray
examination. The main outcomes will be the Cobb angle two years after inclusion and health-
related quality of life.
Discussion: The results of this trial will be of great importance for the discussion on early
treatment for scoliosis. Furthermore, the result will also be important for screening for scoliosis
policies.
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Idiopathic scoliosis (IS) is defined as a lateral curvature of
the spine of unknown origin with a minimal Cobb angle
of 10 degrees. The Cobb angle is the angle between the
upper most inclined vertebra and the lower most inclined
vertebra. Besides a lateral curvature of the spine, there is a
fixed rotation of one or more vertebrae and a rotational
deformation of that vertebra. Once the curvature shows
progression and exceeds a Cobb angle of about 20 to 25
degrees, the curvature is not likely to disappear spontane-
ously. Progression of the curvature usually occurs just
before or during the growth spurt [1].
IS patients who are not fully grown and who have Cobb
angles over 20–25 degrees with established progression of
at least 5 degrees are usually treated with a brace [1]. A
brace is a close fitting device applied to the trunk to try
and prevent further progression of the curvature and
thereby ultimately the need for surgical treatment. Surgi-
cal treatment may become necessary when not fully
grown patients reach Cobb angles over 45–50 degrees [1].
Although many orthopedic surgeons feel that bracing
might slow down progression of IS and some believe that
reduction of the lateral curvature is also feasible, the effec-
tiveness of early treatment of IS with a brace has not yet
been established. No randomized controlled trial (RCT)
on bracing for IS can be found in the Cochrane library or
in PubMed. The majority of the studies are retrospective
cohort studies. Some authors suggest that their results
confirm that the brace is effective [2-4]; others conclude
that the effectiveness of bracing is doubtful or recommend
a RCT [5-8]. Some studies were performed without a con-
trol group; these study results are compared with results
on the natural history from other studies. Another prob-
lem in the interpretation of the results of these studies is
that they lack consistency regarding both inclusion criteria
and the definitions of brace effectiveness [9]. In practice,
there is currently no trial evidence that bracing IS patients
is better than observation and watchful waiting [10-12].
Several Dutch orthopedic surgeons have reached consen-
sus that a RCT is justified under the condition that the
patients included are in an early stage of the clinical
course of scoliosis [5]. In collaboration with these ortho-
pedic surgeons, we formulated the current study design.
At first, serious doubts about this RCT were expressed, par-
ticularly regarding the willingness of IS patients to go
through the process of randomization. In a preliminary
study on the feasibility of a RCT on brace treatment for IS,
we investigated the willingness of IS patients to accept the
process of randomization. We tested the hypothesis that
over 50% of IS patients with an early stage of IS visiting an
orthopedic outpatient clinic, but not yet treated with a
brace for this disorder, would be willing to participate in
a RCT. The opinion of their parents was also explored.
Parents of 30 patients were invited to participate in this
pilot study, of which 21 (70%) agreed to do so. Patients
and their parents were interviewed after receiving written
information about the principle of randomization and
the advantages and disadvantages of participating in a
RCT on the effectiveness of brace treatment. This informa-
tion was also verbally clarified at the beginning of the
interview. In total, 87% of the patients (95%CI: 57% –
91%) and 70% of the parents (95%CI: 48% – 85%)
agreed to participate in a RCT on bracing [13]. Table 1
shows the odds ratio for willingness to participate for
some patient and parent characteristics. Fathers with a
higher secondary education were borderline significantly
more willing to participate in a RCT.
Methods
Setting
Orthopedic surgeons of 10 Dutch hospitals (3 teaching
and 7 non-teaching hospitals) are willing to participate in
this trial. Orthopedic surgeons will verbally inform all
new patients who meet the inclusion criteria about the
trial and give them written information (see table 2).
Patients and their parents are asked for an informed con-
sent. Together these orthopedic surgeons are expected to
recruit 100 patients in a one-year period. All participating
Table 1: Odds ratios (OR) and 95% Confidence Intervals (C.I.) for willingness of parents to let their child participate in a RCT for 
treatment with bracing
Variables Willingness of parents to agree with participation OR (95% C.I.)
Yes No
Age per 1 year rise in age, in the range 9 to 15 years 1.28 (0.76–2.16)
Gender boy girl 6 8 2 5 1.88 (0.27–13.12)
Native country father Netherlands Other countries 12 2 3 4 8.00 (0.96–66.44)
Native country mother Netherlands Other countries 13 1 4 3 9.75 (0.78–121.96)
Educational level father => higher secondary education < higher 
secondary education
9 5 1 6 10.75 (0.99–116.6)
Educational level mother => higher secondary education < higher 
secondary education
7 7 1 6 5.99 (0.56–63.53)Page 2 of 7
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treatment in patients with IS.
Participants
Eligible patients are girls and boys in the age group 8–15
years whose diagnosis of IS has been established by an
orthopedic surgeon, who have not yet been treated by
bracing or surgery, and for whom further growth of phys-
ical height is still expected based on medical examination
and maturation characteristics (Risser sign) established by
X-ray. To expect further growth of physical height, only
patients with a Risser sign ? 2 will be included. All partic-
ipating orthopedic surgeons agreed that the Cobb angle of
the eligible patient should either be minimally 22 and
maximally 29 degrees with established progression of
more than 5 degrees, or should be minimally 30 and max-
imally 35 degrees; established progression for the latter is
not necessary. At inclusion of the study, data on calendar
age, gender, height, maturation characteristics (Risser
sign, menarche), size and location of the curvature will be
recorded for all patients.
Ethical Committee Approval
The Medical Ethical Review Board of the coordinating
hospital approved this trial in December 2005 (MEC-
2005-319). All other participating centers (n = 10)
obtained approval from their local Medical Ethical Com-
mittee between March 2006 and June 2007.
Intervention group
Early treatment of IS consists of wearing a brace that is
intended to prevent the curvature from worsening.
Patients in the intervention group will initially be braced
for two years. The orthopedic surgeon will refer the
patients to a qualified certified prosthetist orthotist who
will measure, make and fit the brace. Each brace will be
measured and modified individually for each patient to fit
and correct her/his curvature. She/he will be advised to
wear the brace every day for 18–23 hours. Boston braces
will be used for all patients; this brace is used the most in
the Netherlands. Patients are usually advised to attend
physical therapy for muscle training and to correct body
posture. Physical therapy alone is not expected to prevent
further progression of the curvature [11]. Therefore,
patients are free to choose whether or not they will attend
physical therapy.
Although some orthopedic surgeons prefer to keep the
patients in the hospital for a few days to allow them to
become used to wearing the brace, others do not. The
orthopedic surgeons are allowed to apply their own pro-
tocol concerning this hospital admission.
In case patients of the intervention group reach Cobb
angles that require surgery, they can be operated.
Table 2: Schematic overview of written information for (parents of) patients with idiopathic scoliosis
Subject Short explanation
Background - explanation what idiopathic scoliosis is
- treatment options in early stages: brace or observation
- effectiveness of brace treatment not established yet
Purpose - establish whether early treatment with a brace prevents curve progression
- evaluate the influence of treatment (brace vs. observation) on health-related quality of life
Design - randomly assigned to brace or observation group by computer, no influence of patient, parent, orthopedic 
surgeon or researcher. 50–50% chance
- all patients examined every four months, both groups same protocol
- 4 times asked to fill in some questionnaires
Advantages and disadvantages - not known yet who will have most advantages. brace group: maybe treated with effective brace; control group: 
delayed/no uncomfortable treatment of which effect has not been established
Risks - both patients treated with a brace as patients being observed have risk on surgery; not yet known whether the 
risk is different between the groups
- regular check-up; in case of progression > 10 degrees in patient in control group, the patient is available for brace
Closure - end results after two years
- depending on the results, again asked to give permission for follow-up until maturity
Voluntary participation - participation is voluntarily, in case of refusal, the usual treatment in that hospital will be provided
- can withdraw permission at any time of the study
Costs and incentive - no extra costs for patients
- no extra incentive for orthopedic surgeons for participation of a certain patient
Confidentiality - all data will be treated confidentially
- no names or data that can lead to identification will be used in rapports etc.
- protocol was approved by medical ethical review board
Insurance - Since no other treatment than currently used in the Netherlands is applied, an extra insurance for patients' safety 
was not necessary
Further information - contact information of the researcher and an independent physician was supplied
Complaints - contact information of a committee that handles complaints about the studyPage 3 of 7
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Patients in the control group will initially not be braced
during the two study years, unless their curvature shows
more than 10 degrees progression compared to the Cobb
angle at inclusion. In this case, the orthopedic surgeon,
patients and their parents could decide to start brace treat-
ment. The patients in the control group are allowed to
attend physical therapy if they want to, because physical
therapy alone will not prevent further progression of the
curvature.
In case patients of the control group reach Cobb angles
that require surgery, they can be operated.
Follow-up
Both the intervention and control group will follow the
same protocol for monitoring the curvature during the
two years of the study. Every four months the orthopedic
surgeons will repeat the measurements of size and loca-
tion of the abnormal curvature, physical height, matura-
tion characteristics (menarche and Risser sign), brace
compliance, and whether or not surgery is indicated.
These examinations will be conducted following a specific
protocol: every four months a physical examination and
an X-ray of the spine will take place. Patients will take off
the brace the night before an X-ray is taken. Standard tech-
nique is a standing position of the patient and a poster-
oanterior projection. In patients with discrepancy in leg
length, boards will be put under the shortest leg to correct
for this.
Objectives
The purpose of this RCT is to establish whether brace
treatment in IS patients with Cobb angles between 22 and
35 degrees significantly reduces further bending of the
spine, thereby preventing surgery for some patients. The
specific research questions are:
1. Will bracing patients with IS in an early stage result in
at least 5 degrees less mean progression of the curvature
compared to the control group after two years of follow-
up?
2. Do differences in health-related quality of life exist
between patients with IS who are treated with a brace and
patients who are under watchful waiting?
3. If bracing proves to be effective, what is the cost-effec-
tiveness of brace treatment, compared to regular surveil-
lance only in terms of cost per avoided surgery and cost
per QALY, accounting for the (increased) burden of brac-
ing and the (reduced) burden of surgery? If bracing does
not appear to be effective, what are the possible savings if
treatment guidelines would be changed?
4. If bracing proves to be effective, what is the cost-effec-
tiveness of the nationwide screening program for scolio-
sis?
Outcomes
The primary outcome of this RCT is that bracing will be
considered potentially effective, if after two years the
mean progression of the abnormal curvature in the inter-
vention group is at least 5 degrees less than in the control
group. Two years after date of randomization the primary
outcome measure, progression in Cobb angle, will be
established in each patient. Mean Cobb angles, as
reported independently, in the intervention arm will be
compared to mean Cobb angles in the control arm. To
reduce inter-observer measurement errors, two ortho-
pedic surgeons associated with the project team will judge
all X-rays independently and without knowledge of the
allocation arm. The mean value of the observed Cobb
angles will serve as assessed value, whenever the differ-
ence between the two measurements is less than 3
degrees. If the difference is larger, a third orthopedic sur-
geon will be asked to measure the Cobb angle; the mean
Cobb angle of all 3 measurements will serve as the
assessed value.
The secondary outcomes of this study concern health-
related quality of life (HRQoL) and compliance to brace
treatment. Because bracing is a burdensome procedure
(including reduced activity in daily living, pain, and
implications for self-esteem, satisfaction with appearance,
and mood), HRQoL will be evaluated in the intervention
and control group by a generic HRQoL questionnaire, i.e.
Child Health Questionnaire-Child Form 87 items (CHQ-
CF87) and the Child Health Questionnaire-Parent Form
50-items, (CHQ-PF50) EuroQol including a VAS for gen-
eral health, and a disease-specific questionnaire, i.e. the
adjusted Scoliosis Research Society-22 Patient Question-
naire for Idiopathic Scoliosis (SRS-22r Patient Question-
naire). These questionnaires have been translated into
Dutch; score distribution and internal consistency corre-
sponded with the original versions [14-16]. Patients will
be asked to fill out the CHQ-CF87, EuroQol and SRS-22
Patient Questionnaire just before every other visit to the
orthopedic surgeon, thus 4 times in total. The EuroQol
scores can be translated into utilities with values from the
Dutch general population. The parents of the patients are
requested to fill out the CHQ-PF50, EuroQol and SRS-22
at the same time that their child fills out her/his question-
naires. Patients and parents will receive the questionnaires
and a return envelope about two weeks before every other
visit to the orthopedic surgeon; thus they can fill out the
questionnaires before they know the results of the X-ray
(i.e., before knowing whether or not the curvature has
progressed).Page 4 of 7
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hours every day as long as the patient is growing, which
often implies wearing the brace during many years in ado-
lescence. Hence, the risk of non-compliance is present.
Lack of compliance in this group would lead to an under-
estimation of the treatment effect, if present, and would
reduce the power of the trial. Compliance will be meas-
ured by three different means. The orthopedic surgeon
will ask the patients and their parents how many hours a
day the patients wear the brace. Because the patient has to
return every 4 months for a check-up, the brace will be
checked for signs of wear and tear typical for an inten-
sively-used brace. Besides this, patients of the intervention
group will receive a short questionnaire in which compli-
ance, attitudes, social influences and barriers to wearing
the brace will be measured at every other visit to the ortho-
pedic surgeon.
Sample size
The Cobb angle at inclusion will on average be 29 degrees
(range 22–35 degrees). Due to the standard error of radi-
ographic production and intra and inter-observer meas-
urement variation, a measurement error in Cobb angles of
5 degrees will appear [1]. To reduce the standard error of
radiographic production, all patients will undergo X-ray
following a strict protocol. Because inter-observer meas-
urements errors are reduced (see Outcomes), measurement
error will than be maximal 2 degrees, thus the 95% obser-
vation interval of Cobb angles at inclusion is 20–37
degrees. After two years, when the outcome will be deter-
mined, the range in change will be 0–15 ± 2 degrees.
Assuming a uniform distribution of this change in Cobb
angle between the patients after two years (most unfavo-
rable scenario), the standard deviation of the difference in
change between baseline and outcome measurement will
be about 4.5 degrees.
Since bracing has to be better than observation to be jus-
tified as treatment for IS, a superiority design will be used.
With a power of 95% and alpha = 0.05, a mean difference
of 5 degrees between the groups can be detected with 40
patients in both study arms. We will aim at a study popu-
lation at start of 100 patients to take loss to follow-up into
account.
Randomization
Patients and their parent(s) who decide to participate will
be asked to return the informed consent form to the
researchers. Upon receipt of this form, randomization will
be performed centrally by the department of Public
Health (Erasmus MC) using computer-generated lists.
Lists will be constructed with randomly permuted blocks
per stratum, where strata will be defined by the participat-
ing center. The orthopedic surgeon will notify the patients
and their parents of the outcome of allocation to the inter-
vention group or the control group.
Blinding
In this study, blinding of patients and orthopedic sur-
geons for treatment is not possible. However, a proper,
blindly and independently conducted judgment of the X-
rays in both trial groups is essential for the primary out-
come. Two orthopedic surgeons will judge all X-rays of the
patients of both groups and calculate the Cobb angles. To
ensure blinding of the primary outcome, the randomiza-
tion status of the participants will not be disclosed to
these two orthopedic surgeons, who judge the patient's X-
rays.
Statistical methods
The intervention and control group will be compared
based on the 'intention to treat' principle. Differences in
Cobb angle between the two groups and other continuous
parameters will be measured using parametric or non-par-
ametric tests (depending on skewness) for group compar-
isons. Categorical parameters will be compared by the
Chi-square test. Logistic regression will be applied to
measure the treatment effect (yes/no progression) adjust-
ing for covariates. Since we have 4-month measurements
on Cobb angles in both arms, progression in Cobb angle
will be analyzed with a linear mixed effect model, where
we will assume a simple compound symmetry structure.
This may be particularly important for extrapolations to
follow-up periods longer than 2 years after entry.
When a patient in the control group had to be braced
before the end of the follow-up (because of a more than
10 degree progression of the curvature), her/his Cobb
angle at the moment of commencing treatment will be
considered as final outcome and will be included in the
analysis.
In a second analysis, we will perform Kaplan-Meier anal-
yses with these 'progression to more than 10 degrees' as
events, in both arms (intention-to-treat).
Stratified analysis will be done to evaluate whether curve
type, brace compliance, Cobb angle at inclusion and
Risser sign at inclusion influence the effectiveness of brace
treatment. Using logistic regression we will also evaluate
whether brace compliance depends on gender and age.
Health-related quality of life and utilities will be com-
pared between the intervention and control group. This
will be done by basic descriptive statistics. Depending on
the distribution of the data, parametric or non-parametric
tests will be used.Page 5 of 7
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In collaboration with Dutch orthopedic surgeons we have
designed the first randomized controlled treatment trial
and started it in 2006. In 2007, dr. Weinstein et al. also
started a randomized controlled treatment trial on bracing
in the USA (BrAIST) [17]. The results of these trials will be
of great importance to the discussion on bracing patients
with IS. At the moment, patients and parents face a
dilemma, because the only available treatment has not
been proven effective, and is a rather burdensome one.
The results of this study will also be valuable for the
screening program for scoliosis. Screening aims at detect-
ing scoliosis in an early stage of the clinical course to allow
brace treatment to try and prevent further progression of
the curvature and reducing the need for surgery [11].
Recently, we performed a case control study on the effec-
tiveness of screening for scoliosis. In that study, the case
group consisted of surgically treated IS patients (the con-
dition screening and early treatment should prevent) and
the control group consisted of a random sample of Dutch
youth. We found no evidence that cases were significantly
less screened than controls [18]. If we had found a posi-
tive effect of screening, that would have implied that brac-
ing is effective. A RCT on the effectiveness of bracing now
seems even more justified. If bracing shows to be effective,
the screening program needs to be revised. If bracing
doesn't prove to be effective, a screening program is not
applicable, since the availability of an effective early treat-
ment is one condition for a screening program to be justi-
fied [19].
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